As for drug resistance, related research found that H19 could be secreted into exosomes assisted by heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2B1) and induce gefitinib resistance in NSCLC cells (51). Here, HNRNPA2B1 is linked to non-small cell lung carcinoma.